Studies on STAT3 report its involvement in various autoimmune disorders, including inflammatory bowel disease (IBD), in which its activation in acquired immunity results in a pathogenic role in colitis, whereas its activation in innate immunity results in a suppression of colitis [46]. The gene discussed is STAT3; the disease is colitis.